title: [Non-transferrin-bound iron: a promising biomarker in iron overload disorders].
abstract: Iron overload disorders are common and, if left untreated, severe systemic diseases that can have both genetic and acquired causes. Hereditary haemochromatosis, β-thalassaemia, myelodysplastic syndromes and sickle cell disease are among the most important examples. Iron that is not bound to transferrin, haem or ferritin (non-transferrin-bound iron, NTBI) seems to play a key role in the pathophysiology of these disorders. NTBI is a heterogeneous group of potentially toxic iron complexes in plasma which are generated almost exclusively under pathological conditions. Cellular uptake of NTBI contributes to its toxicity and is mediated by several organ-specific transporters and receptors. NTBI-induced toxicity is the result of oxidative damage to various macromolecules by reactive oxygen species (ROS). In the near future, we hypothesize that NTBI will have important implications for both diagnosis and treatment of iron overload disorders. However, before NTBI can be applied to patient care, the currently available assays need further clinical and analytical validation.
authors.affiliation: Radboudumc, Nijmegen.
authors.forename: Roderick P P W M
authors.initials: RP
authors.lastname: Maas
authors.forename: Philip J G M
authors.initials: PJ
authors.lastname: Voets
authors.forename: Louise
authors.initials: L
authors.lastname: de Swart
authors.forename: Dorine W
authors.initials: DW
authors.lastname: Swinkels
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D015415:Biomarkers / Q000097:blood* / Q000737:chemistry; D006432:Hemochromatosis / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007501:Iron / Q000737:chemistry / Q000378:metabolism*; D019190:Iron Overload / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D010084:Oxidation-Reduction; D017382:Reactive Oxygen Species; D014168:Transferrin / Q000378:metabolism / Q000627:therapeutic use; D017086:beta-Thalassemia / Q000097:blood / Q000175:diagnosis / Q000628:therapy
chemical_list: D015415:Biomarkers; D017382:Reactive Oxygen Species; D014168:Transferrin; D007501:Iron